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Abstract
Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has been described.
However, the molecular mechanism of PLP for the inhibition of liver fibrosis is unclear. This study aims to
investigate the molecular protein signatures involved in the hepatoprotective mechanisms of PLP via a proteomics
approach using a thioacetamide (TAA)-induced liver fibrosis rat model.
Methods: Male Sprague–Dawley rats were divided into three groups of six as follows: Normal group; TAA group, in
which rats received TAA only; and PLP group, in which rats received PLP and TAA. Liver fibrosis was induced in the
rats by repeated intraperitoneal injections of TAA at a dose of 200 mg/kg body weight twice a week for 4 weeks.
PLP was given orally at a dose of 50 mg/kg body weight twice a day from the beginning of the TAA treatment
until the end of the experiment. The development of liver cirrhosis was verified by histological examination. Liver
proteomes were established by two-dimensional gel electrophoresis. Proteins with significantly altered expression
levels were identified by matrix-assisted laser desorption/ionization-time of flight/time of flight mass spectrometry
and the differentially expressed proteins were validated by immunohistochemical staining and reverse transcription
polymerase chain reaction.
Results: Histological staining showed a remarkable reduction in liver fibrosis in the rats with PLP treatment. A total
of 13 differentially expressed proteins including actin, tubulin alpha-1C chain, preprohaptoglobin, hemopexin,
galectin-5, glutathione S-transferase alpha-4 (GSTA4), branched chain keto acid dehydrogenase hterotetrameric E1
subunit alpha (BCKDHA), glutathione S-transferase mu (GSTmu); glyceraldehyde-3-phosphate dehydrogenase
(GAPDH); thiosulfate sulfurtransferase (TFT); betaine-homocysteine S-methyltransferase 1 (BHMT1); quinoid
dihydropteridine reductase (QDPR); ribonuclease UK114 were observed between the TAA and PLP groups. These
proteins are involved in oxidative stress, heme and iron metabolism, cysteine metabolism, and branched-chain
amino acid catabolism.
Conclusion: The proteomics data indicate that P. linteus may be protective against TAA-induced liver fibrosis via
regulation of oxidative stress pathways, heat shock pathways, and metabolic pathways for amino acids and nucleic
acids.
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Background
Most chronic liver diseases, including viral hepatitis
(hepatitis B virus and hepatitis C virus), alcoholic liver
disease, and biliary diseases [1], ultimately lead to liver
fibrosis. Without effective treatments at an early stage,
reversible liver fibrosis will lead to irreversible cirrhosis
[2]. Oxidative stress may cause liver damage [3,4], and
reducing oxidative stress by supplementation with anti-
oxidants is effective for preventing liver fibrogenesis [5].
However, evidence for the efficacy of antioxidants, such
as vitamin E and superoxide dismutase, in the treatment
of human liver fibrosis has not been established [6].
Phellinus linteus (Berk. et Curt.) Teng, an orange-
colored mushroom, belongs to the Hymenochaetaceae
Basidiomycetes and has been considered useful in pre-
venting and treating liver fibrosis and liver cancers
owing to its strong anti-inflammatory, antioxidative,
antiangiogenic, and anticancer properties [7-10]. P.
linteus has been used in Chinese medicine for the treat-
ment of tumors, menstrual irregularities, and liver-
related illnesses [11]. Several reports from Korea and
Japan have demonstrated that intake of P. linteus for a
long time may induce spontaneous regression of hepa-
tocellular carcinoma in patients with multiple metasta-
ses [12,13]. Some in vivo and in vitro studies have also
demonstrated that P. linteus exerts antitumor effects on
hepatocellular carcinoma [14-16].
Over the last decade, accumulating evidence suggests
that P. linteus may protect the liver against fibrosis via
its antioxidative property. A study in 2002 demonstrated
that an extract of P. linteus was able to suppress carbon
tetrachloride-induced late liver fibrosis by reducing per-
oxidation products, restoring the activities of catalase
and superoxide dismutase, and reviving the expression
of aerobic respiration enzymes [11]. Shon et al. [11]
demonstrated that a P. linteus polysaccharide (PLP) frac-
tion was able to inhibit cytochrome P450 isozymes in
the liver. Furthermore, a retinoic acid derivative isolated
from P. linteus was reported to decrease transforming
growth factor-beta-induced early liver fibrosis by down-
regulating reactive oxygen species generation and sup-
pressing the expression of several proteins [11].
Although antioxidation is an important mechanism by
which P. linteus suppresses liver fibrosis, the molecular
mechanism of the antioxidative effect of P. linteus is still
unclear. To date, studies on P. linteus-mediated protection
of the liver against injury have only found a few target
molecules [17]. With the development of proteomics tech-
nology, it is possible to cover the expression of more pro-
teins acting within a biological context to investigate the
cellular processes involved in disease pathogenesis with
high-throughput and in a quantitative manner [18,19].
In the present study, we aim to assess the hepatopro-
tective effects of P. linteus against thioacetamide (TAA)-
induced liver fibrosis by high-resolution two-dimen-
sional polyacrylamide gel electrophoresis (2-DE) coupled
with mass spectrometry technology.
Methods
Preparation of PLP
Sang Hwang 125 capsules containing a lyophilized hot
water extract of wild-type P. linteus were donated by Dr.
Frankie Chan (Amazing Grace Health Products Limited
Partnership, Thailand). Each Sang Hwang capsule con-
tained 400 mg of pure extracts from natural P. linteus.
The polysaccharides and glucan contents of the P. lin-
teus natural compound are 53–63% and 24%, respect-
ively, as previously reported by us [20]. This natural
compound has been shown to possess strong antioxida-
tive and immunomodulatory properties [21]. PLP was
prepared by dissolving 100 g of freeze-dried powder
from Sang Hwang 125 capsules in 1 L of distilled water,
followed by the addition of 2 L of ethanol (Merck, Ger-
many) at −20°C. The precipitated polysaccharides were
collected by centrifugation at 3000 × g for 1 h, dissolved
in a small volume of distilled water, and lyophilized. The
resulting powder was stored at −20°C until use.
Animal experiments
Eight-week-old male Sprague–Dawley rats (weighing
approximately 200 g) were obtained from Hallym Uni-
versity (Korea). All rats were kept in an animal house
under a 12-h/12-h light/dark cycle, with controlled
temperature and humidity and free access to food and
water. After 1 week of acclimatization, the rats were
arbitrarily divided into three groups: Normal group;
TAA group, in which rats received TAA only; and PLP
group, in which rats received PLP and TAA. TAA
(Sigma-Aldrich, USA) was intraperitoneally injected at
a dose of 200 mg/kg body weight twice a week for 4
weeks. PLP was given orally at a dose of 50 mg/kg
body weight twice a day from the beginning of the
TAA treatment until the end of the experiment. All
rats were euthanized after 4 weeks by intraperitoneal
injection of 200 mg/kg sodium pentobarbital (Sigma-
Aldrich, USA). Dissection was carried out, and liver
samples were fixed in 10% buffered formalin solution
(Surgipath, Germany) for histological staining. Tissues
from the same portion of the liver were collected from
the TAA and PLP groups for the proteomics analysis.
The study protocol was approved by the Hallym Uni-
versity, South Korea. Animal care complied with institu-
tional guidelines.
Histological examination of the liver
The fixed liver tissues were embedded in paraffin and
sectioned at 5-μm thickness. For each liver sample, the
stage of hepatic fibrosis was established. The liver
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sections were stained with Masson’s trichrome (Sigma-
Aldrich, USA) and observed under NIKON model SE
microscope (NIKON, Japan) to evaluate the degree of
fibrosis.
Sample preparation for proteomics analysis
Liver samples were snap-frozen in liquid nitrogen and
stored at −80°C for the proteomics analysis. The frozen
liver tissue samples from the TAA and PLP groups were
disrupted with a tissue teaser (Biospec Products, USA)
in a lysis buffer containing 25 mM HEPES, pH 7.5, 150
mM NaCl, 1 mM EDTA disodium salt, 1 mM dithio-
threitol (DTT) (USB, USA), 1% (v/v) Triton X-100 (USB,
USA), and 1% (v/v) Protease Inhibitor Cocktail Set III
(Bio-Rad, USA). The superfluous salt in the extract was
removed by incubation with 20% (w/v) trichloroacetic
acid (TCA)-acetone solution and 20 mM DTT in acet-
one (Merck, Germany) for 4 hours at −40°C. The protein
pellet was obtained by centrifugation at 15,800 × g for
30 min at 4°C. Excess TCA was removed by three
washes with acetone containing 20 mM DTT. After air-
drying, the protein pellet was resuspended in buffer
comprising 7 M urea, 2 M thiourea, 100 mM DTT, 5%
(v/v) glycerol, and 4% (w/v) 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate (CHAPS) (USB,
USA), and the resulting protein solution was stored at
−80°C until 2-DE analysis. The protein concentration
was determined by the Bradford assay (Bio-Rad, USA).
Two-dimensional gel electrophoresis
The 2-DE procedures were performed according to our
previous study [22] with some modifications. The tissue
samples were processed in duplicate and a total of 12
gels (six for the TAA group and six for the PLP group)
were used. For the first-dimension electrophoresis, 100-
μg protein samples were mixed with 350 μL of rehydra-
tion buffer comprising 9.5 M urea, 2% (w/v) CHAPS,
0.28% (w/v) DTT, 0.002% (w/v) bromophenol blue (USB,
USA) and 1% (v/v) immobilized pH gradient buffer (pH
3–10) (Bio-Rad, USA), and then applied to an Ettan
IPGphor 3 isoelectric focusing electrophoresis system
(GE healthcare, USA). The samples were rehydrated for
7 h before isoelectric focusing with the following pro-
grams: (a) linear increase up to 500 V over 1 h; (b) hold-
ing at 500 V for 2 h; (c) linear increase up to 10,000 V
over 4 h; (d) linear increase up to 10,000 V over 3 h; and
(e) final hold at 10,000 V to reach a total of 120,000 V ×
h. The focused immobilized pH gradient gel strips were
equilibrated for 15 min in a solution comprising 50 mM
Tris–HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2%
(w/v) sodium dodecyl sulfate (SDS) and 20 mM DTT, fol-
lowed by incubation with the same buffer containing 20
mM iodoacetamide (Sigma-Aldrich, USA) for another 15
min. The second-dimension separation was performed
by 12.5% SDS polyacrylamide gel electrophoresis (PAGE)
at a constant current of 30 mA for 30 min, followed by a
60-mA current for the rest of the analysis until the bro-
mophenol blue line reach the bottom of the gels.
Image acquisition and analysis
After the 2-DE, the gels were stained with SYPROW Ruby
Protein Stain (Bio-Rad, USA) according to the manufac-
turer’s protocol. The stained gels were scanned with a
Molecular Imager PharosFX Plus System (Bio-Rad, USA)
and analyzed by PDQuest 8.0 software (Bio-Rad, USA).
Each expression level was calculated as the percentage
volume (% vol), and exported for statistical analysis. The
relative intensities of spots were used for comparison be-
tween the two groups, and only those spots with signifi-
cant differences (≥ 1.5-fold increase or decrease; P <
0.05) were selected for protein identification.
Protein identification
Spots showing differential expression (P < 0.05) between
the TAA and PLP groups were sent to the Genome Re-
search Centre (The University of Hong Kong, Hong
Kong) for protein identification. The proteins were
digested with sequencing grade modified trypsin (Pro-
mega, USA) and applied to matrix-assisted laser desorp-
tion/ionization-time-of-flight/time-of-flight (MALDI-
TOF/TOF) mass spectrometer analysis using a 4800
MALDI TOF/TOF Analyzer (Applied Biosystems, USA).
Matches between the experimental data and mass values
calculated from a candidate protein were carried out by
Mascot search engine (Matrix Science, UK) that uses MS
data to identify proteins from the NCBInr database with
taxonomy limited to Rattus norvegicus. The database
allowed up to one missed cleavage and the mass toler-
ance was set as 75 ppm peptide limited by fixed modifi-
cation of carbamidomethyl and variable modification of
oxidation, with monoisotopic values. Mascot reported
the molecular weight search (MOWSE) score, which is
calculated by −10 × log10 (P), where P is the probability
that the observed match is a random event. The P value
is limited by the size of the sequence database being
searched (limited by taxonomy), the conditions, and the
settings of trypsin digestion. Each calculated value that
falls within a given mass tolerance of an experimental
value counts as a match. The accepted threshold is that
an event is significant if it would be expected to occur at
random with a frequency of < 5%. In this study, a protein
match with a score of > 71 was regarded as significant.
Western blot analysis for validation of differentially
expressed proteins
Western blot analysis was employed to validate the
proteomic data. Liver protein extracts were mixed with
sample buffer (62.5 mM Tris–HCl, pH 6.8, 25% (v/v)
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glycerol, 2% (w/v) SDS, 350 mM DTT, and 0.01% (w/v)
bromophenol blue) at a ratio of 1:1 and incubated in
boiling water for 5 min. Aliquots of the samples (30 mg
of protein) were separated by electrophoresis in 12.5%
SDS-PAGE gels at constant voltage (120 V) and then
transferred to polyvinylidene difluoride membranes (GE
Healthcare, USA) using a TE77 PWR Semi-dry Transfer
Unit (GE Healthcare, USA). The membranes were
blocked with 5% (w/v) non-fat dry milk in phosphate buf-
fer saline overnight at 4°C. The membrane was incubated
with primary antibodies: anti-haptoglobin (1:1000), anti-
hemopexin (1:1000;), anti-hemoglobin (1:1000), anti-
GSTA4 (1:500), and anti-GSTmu (1:1000) (Abcam, USA)
for one hour and then incubated with their correspond-
ing secondary horseradish peroxidase-conjugated anti-
bodies (Bio-Rad, USA) for another one hour. The blots
were washed five times with 0.05% Tween-20 in phos-
phate buffer saline between steps. Proteins were detected
with an enhanced chemiluminescence system (GE
Healthcare, USA) and the band intensity was measured
with the Quantity One software (Bio-Rad, USA).
Reverse transcription polymerase chain reaction
Reverse transcription polymerase chain reaction (RT-
PCR) was employed to verify the differentially expressed
proteins identified by the proteomics analysis. Total
RNA was extracted from liver samples in the TAA and
PLP groups using TRIzolW (Invitrogen, USA). Aliquots
of the total RNA (5 μg) were reverse-transcribed with
Super Script III (Invitrogen, USA) in the presence of
oligodeoxythymidylic acid primers (Sigma-Aldrich,
USA) according to the manufacturer’s instructions.
PCR was performed with an iCycler Thermal Cycler
(Bio-Rad, USA). cDNA (0.5 μL) were used for each
PCR amplification in a total reaction volume of 15 μL
using iQ SYBR Green Super Mix (Bio-Rad, USA), and
all reactions were performed in duplicate. A total of
11 genes were examined, including ribonuclease
UK114, hemopexin, preprohaptoglobin, glutathione S-
transferase alpha-4 (Gsta4), branched chain keto acid
dehydrogenase heterotetrameric E1 subunit alpha
(Bckdha), glyceraldehyde-3-phosphate dehydrogenase
(Gapdh), haptoglobin, thiosulfate sulfurtransferase (Tft),
betaine-homocysteine S-methyltransferase 1 (Bhmt1),
quinoid dihydropteridine reductase (Qdpr), and dihydro-
folate reductase (Dhfr) because they showed significantly
different expression levels in the 2-DE proteomics ana-
lysis, plus ubiquitin C as an internal control. The primers
in Table 1 were used for the PCR with mentioned anneal-
ing temperature. The amplification was initiated by 4 min
Table 1 Primers used for the PCR analyses
Gene Primer sequence (5’-3’) Fragment size (bp) Annealing temperature (°C)
Preprohaptoglobin F1: TGCCTATCTGCCTGCCTTC 316 58
R2: GTGTCCTCCTCCGTGTCAT
Hemopexin F: AAGCCAGACTCAGATGTAA 479 55
R: AAGCAGTAGTAGCGTTCA
Gsta4 F: GGACCTGATGATGATGATTATC 446 54
R: TATCTTGCCTCTGGAATGC
Bckdha F: AGCGTCACTTCGTCACCATT 547 60
R: GCCTTCTCCTGTTCCTCATCC
Bhmt F: CAGACACCTTCCTACCTCAG 281 52
R: CAGTTCACACCGACAATGG
Dhfr F: CTTGACGGCACTCTAAGC 304 52
R: CTCCTTGTGGTGGTTCCT
Qdpr F: GATGTGGTGGAGAATGAAGAGG 241 56
R: AGTGGCTAGAGATGGTGGATG
Gapdh F: CATGACCACAGTCCATGCCATC 451 60
R: CACCCTGTTGCTGTAGCCATATTC
Uk114 F: GCATGTCGTCAATAATCAGA 443 54
R: CTCCAGAGTCAGCATCAG
Tft F: GGTTCATCAGGTGCTCTATCG 311 58
R: CCAGGTCGTCTCCATCGTATA
Ubiquitin C F: TGGAGGTCGAGCCCAGTGTTA 105 58
R: CCCAAGAACAAGCACAAGAAGGGCT
1F: Forword.
2R: Reverse.
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denaturation at 94°C for 1 cycle, followed by 30 cycles at
94°C for 30 s, specially annealing temperature of each
gene for 30 s, and 72°C for 1 min using a Bio-Rad Icycler
PCR thermocycler 96 well thermal thermo cycler (Bio-
Rad, USA). After the last cycle of amplification, samples
were incubated for 7 min at 72°C. The PCR products were
examined in 1% agarose gels stained with 0.01% SYBRW
Safe DNA Gel Stain (Invitrogen, USA) and analyzed using
Quantity One software (Bio-Rad, USA).
Statistical analysis
All data are presented as the mean ± standard deviation
(SD). The significance of differences in data between the
groups was determined by one-way analysis of variance
followed by the Tukey test for equality of variances using
SPSS 17.0 (IBM, USA). Differences were considered sta-
tistically significant at P < 0.05.
Results
Histological assessment of liver fibrosis
TAA treatment of rats for 4 weeks resulted in liver fibro-
sis, which was characterized by alterations in the quality
of the hepatic extracellular matrix (Figure 1B&C), com-
pared with the livers of rats in the Normal group
(Figure 1A). Extended collagen deposition and large
septa of the hepatic lobules were observed after 4 weeks
of TAA treatment (Figure 1B). In addition, lymphoid in-
filtration was observed around the central and portal
veins in the TAA-treated livers. PLP treatment markedly
reduced the severity of the fibrosis and inflammation
induced by TAA (Figure 1C).
Identification of protein spots on 2-DE gels
On each 2-DE gel, nearly 1000 individual protein spots
were detected, and 13 spots with notable changes found
by the PDQuest software between the PLP and TAA
groups were identified by MS (Figure 2, Table 2). The
proteins with increased expression levels in the PLP
group compared with the TAA group included actin
cytoplasmic 2, tubulin alpha-1C chain, galectin-5,
BCKDHA, DHFR, preprohaptoglobin, GSTA4, QDPR,
GAPDH, and TFT. The proteins with decreased expres-
sion levels in the PLP group compared with the TAA
group were hemopexin, ribonuclease UK114, and
BHMT1.
Western blot analysis for validation of differentially
expressed proteins in the proteomics analysis
Owning to the limitations of anti-rat protein antibodies,
many of the identified differentially expressed proteins
could not be measured by western blot analysis. Hapto-
globin, hemopexin, heat-shock protein 70 (HSP70), and
GSTA4 were successfully measured and used to validate
the results obtained in the proteomic analysis. The west-
ern blot results were in general agreement with the dif-
ferentially expressed proteins obtained in the proteomic
analysis. As shown in Figure 3, the level of hemopexin
(P = 0.049) was lower and the levels of haptoglobin (P =
0.042) and GSTA4 (P = 0.040) were much higher in the
PLP group compared with the TAA group. The levels of
hemoglobin (P = 0.047) and HSP70 (P = 0.041) were
higher in the PLP group than in the TAA group. GSTmu
did not show a significant difference in the western blot
analysis.
Quantitative RT-PCR for gene expression analysis
To investigate whether the expression changes of the
identified proteins occurred at the transcriptional level,
we determined the mRNA expression changes of these
proteins by semiquantitative RT-PCR. As shown in
Figure 4, the mRNA expression of many of the identi-
fied genes changed in a similar tendency as their pro-
tein expression change showed in 2D proteomic results,
suggesting that the effects of P. linteus were exerted at
the protein expression level, i.e. focused on the transla-
tion and post-translation steps. Haptoglobin, BCKDHA,
and BHMT showed significant differences between the
TAA and PLP groups.
Figure 1 Photomicrographs of rat livers. The livers were sectioned at 5-μm thickness and the sections were stained with Masson’s
trichrome. A: Normal group. B: TAA group. C: PLP group. Extended collagen deposition and large septa of the hepatic lobules are observed in the
TAA-treated liver (B) compared with the normal liver (A). In addition, lymphoid infiltration is observed around the central and portal veins in the
TAA-treated liver. PLP treatment markedly reduces the severity of the fibrosis and inflammation induced by TAA (C).
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Discussion
The present study demonstrates that a natural product
derived from P. linteus was able to protect against liver
fibrosis induced in rats by chronic insult with TAA. The
histopathological data clearly showed a reduction in col-
lagen accumulation in the liver with PLP treatment. The
present study thus supports the earlier findings that P.
linteus possesses the capability to suppress liver injury
[17,23] and exhibits strong and specific inhibitory activ-
ities to reduce peroxidation products and increase anti-
oxidant enzymes in the liver [17,23].
By using a 2-DE gel proteomics approach, we identi-
fied 13 differentially expressed hepatic proteins in the
TAA-induced liver fibrosis rats in response to PLP treat-
ment. Of these, 10 proteins showed increased expression
and three proteins showed reduced expression, and the
expression changes ranged from ±1.5-fold to ±2.5-fold
(Figure 5). When these proteins are categorized accord-
ing to their biochemical and physiological functions, we
found associations with oxidative responses, molecular
chaperones, heme and iron metabolism, cysteine metab-
olism, branched-chain amino acid metabolism, energy
Table 2 Differentially expressed liver proteins between the TAA-induced liver fibrosis rats in the PLP and TAA groups
Spot
No.1
Protein name GenInfo
identifier2
Protein
score3
Expression
quantity
(×102) TAA
Expression
quantity
(×102) PLP
Expression
change
(PLP/TAA)
P pI4 Mr
(kDa)4
1011 actin, cytoplasmic 2 gi|4501887 65 62.6 ± 24.5 97.1 ± 13.0 1.6 0.012 5.31 42.1
1619 tubulin alpha-1C chain gi|58865558 254 29.4 ± 13.0 55.4 ± 14.0 1.9 0.014 4.96 50.6
3802 hemopexin gi|122065203 262 100.5 ± 34.1 61.4 ± 15.4 −1.6 0.028 7.58 52.0
5011 galectin-5 gi|785053 120 11.5 ± 9.5 75.3 ± 44.9 6.5 0.028 6.95 15.5
5514 Bckdha protein gi|59808237 88 41.3 ± 9.1 61.0 ± 11.5 1.5 0.008 6.4 37.6
7113 dihydrofolate reductase gi|18426814 100 49.3 ± 14.7 73.8 ± 14.0 1.5 0.015 6.77 21.7
7126 Glutathione S-transferase alpha-4 gi|157820217 67 15.1 ± 7.6 28.9 ± 11.3 1.9 0.033 6.77 25.6
7203 preprohaptoglobin gi|204657 75 54.8 ± 20.6 92.5 ± 16.2 1.7 0.005 7.16 30.4
8005 ribonuclease UK114 gi|47168636 159 172.2 ± 69.2 78.9 ± 45.1 −2.2 0.020 7.79 14.4
8110 quinoid dihydropteridine reductase, isoform CRA_c gi|149047263 135 83.7 ± 22.3 128.5 ± 25.5 1.5 0.009 9.69 27.9
8207 betaine-homocysteine S-methyltransferase 1 gi|13540663 142 128.6 ± 42.6 65.1 ± 12 −2.0 0.006 8.02 45.4
8305 glyceraldehyde-3-phosphate dehydrogenase gi|8393418 130 141.6 ± 69.1 225.8 ± 44.3 1.6 0.035 8.14 36.1
9308 thiosulfate sulfurtransferase gi|57528682 256 63.8 ± 15.7 99.7 ± 22.8 1.6 0.010 7.71 33.6
1Spot no.: automatically assigned by the PDQuest software.
2GenInfo identifier: sequence identification number assigned by GenBank.
3Protein score: generated by the MS identification system.
4Mr and pI: relative molecular mass (Mr) and isoelectric point (pI) generated by the MS system.
Figure 2 Representative 2-DE gel maps of the liver proteomes of rats in the TAA (A) and PLP (B) groups.
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metabolism, and glutathione metabolites (Table 3).
Among these 13 proteins, the regulation of hemopexin,
preprohaptoglobin, GSTA4, BHMT, BCKDHA, QDPR,
DHFR, and galectin-5 expression could be important in
the protective effects of P. linteus against liver fibrosis.
The proteomic data showed that the expression of pre-
prohaptoglobin was 1.7-fold higher while that of hemo-
pexin was 1.6-fold lower in the PLP group compared
with the TAA group. The expression changes of these
two proteins were validated by western blot analysis
(Figure 3). The increase in hemopexin and decrease in
haptoglobin are potential markers for fibrosis because of
their involvement in the regulation of liver iron homeo-
stasis [24]. The aspect of whether the protective effect of
PLP against the TAA-induced liver fibrosis occurred via
the regulation of iron homeostasis cannot be concluded
in the present study, because the liver and serum iron
concentrations were not determined. In a previous
study, chelation of ferrous ions by P. linteus was
described, and PLP was able to protect hepatocytes
against iron overload-mediated oxidative stress [21]. Iron
homeostasis regulation has been suggested as a potential
PLP treatment target in liver fibrosis [25].
Glutathione (GSH) plays an important role in cellular
detoxification, because it effectively scavenges free radi-
cals and other reactive oxygen species. In GSH-related
antioxidative detoxification, glutathione S-transferases
(GSTs) play central role; GSTA4 plays a role in the cellu-
lar defense against oxidative stress and lipid oxidation
during liver injury [26]. Dwivedi et al. [27] demonstrated
that mGSTA4 null (−/−) mice showed much quicker
and greater carbon tetrachloride-induced hepatotoxicity
than wild-type (+/+) mice. In the present study, the ex-
pression of GSTA4 was 1.9-fold higher in the PLP group
than in the TAA group, and the change was confirmed
by western blot analysis. The upregulated expression of
GSTA4 might protect the liver against the injury and
oxidative stress induced by TAA. However, the western
blot analysis did not show a significant change in
GSTmu between the PLP and TAA groups. These
results could arise through non-specificity of the anti-
body for GSTmu or because GSTA4 was likely to be
regulated by P. linteus.
The expression of BHMT was 2-fold lower in the PLP
group than in the TAA group, suggesting that homocyst-
eine was inclined to be converted to cysteine in the
transsulfuration reaction, generating more cysteine for
GSH synthesis. P. linteus may promote the accumulation
of substrates for GSH synthesis, cysteine and glutamate
[28], by regulating the expression levels of BHMT and
BCKDHA [29]. BHMT reduces the conversion of homo-
cysteine to cysteine by catalyzing the remethylation of
homocysteine back to methionine [30].
Branched-chain amino acid (BCAA) catabolism is an
important intercellular source of glutamate [31]. The
branched-chain α-keto acid dehydrogenase (BCKD)
complex is the rate-limiting enzyme for the whole
BCAA catabolism. The Bckdha gene encodes the E1 α
subunit of the BCKD [32]. The expression of BCKDHA
was 1.5-fold higher in the PLP group than in the TAA
group, suggesting that more glutamate was generated for
GSH synthesis in the PLP group.
Several proteins that showed higher expression in the
PLP group are involved in amino acid metabolism and
nucleic acid metabolism. These include BCKDHA (1.5-
Figure 3 Western blot measurements of the haptoglobin,
hemopexin, GSTA4, hemoglobin, HSP70, and GSTmu
expression levels in the TAA-induced fibrotic livers with and
without PLP treatment. The protein expression levels are
presented as means ± SD (N = 6). *P < 0.05 vs. the TAA group.
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fold), QDPR (1.6-fold), and DHFR (1.5-fold). In clinical
treatment of liver diseases, supplementation with
BCAAs is considered useful to relieve protein malnutri-
tion [33,34]. QDPR is an enzyme that takes part in the
tetrahydrobiopterin recycling pathway, and tetrahydro-
biopterin is the precursor of phenylalanine and tyrosine
[35]. The higher expression of QDPR in the PLP group
suggests that PLP may expedite protein and nucleic acid
synthesis in the fibrotic liver. DHFR is important for
regulating the cellular amount of tetrahydrofolate, which
is essential for purine and thymidylate synthesis [36,37].
The higher expression of DHFR in the PLP group
indicates that PLP may aid in the regeneration of liver
injury. The expression of ribonuclease UK114, a trans-
lational inhibitor mostly present in the liver and kidney,
was 2.2-fold lower in the PLP group, meeting the re-
quirement for protein synthesis for liver regeneration. In
a clinical study, downregulation of ribonuclease UK114
was observed in human hepatocellular carcinoma [38].
GAPDH catalyzes a step of glycolysis. The expression
of GAPDH was 1.6-fold higher in the PLP group, sug-
gesting a higher energy requirement for liver amelior-
ation. Several studies have illustrated that GAPDH may
work in non-metabolic processes, such as transcription
regulation [39] and apoptosis initiation [40,41]. This may
be another reason for the upregulation of GAPDH in
the PLP group.
Galectins comprise a family of evolutionarily con-
served glycan-binding proteins that take part in acute
and chronic inflammation [42,43]. Galectin-5 contri-
butes to erythrocyte differentiation and reticulocyte
Figure 5 Effects of PLP on the expression changes of
significantly altered proteins involved in TAA-induced liver
fibrosis (PLP/TAA).
Figure 4 Semiquantitative RT-PCR analyses of the effects of PLP on the gene expression changes of significantly altered proteins
during TAA-induced liver fibrosis. The mRNA expression levels are presented as means ± SD (N = 6). *P < 0.05,**P < 0.01 vs. the TAA group.
Table 3 Major biofunctions of the identified proteins
Protein name Subcellular location Major functions
Anti-oxidant effects
hemopexin Extracellular region The highest binding
affinity for heme, iron
metabolism
preprohaptoglobin Extracellular region The highest binding
affinity for
hemoglobin
glutathione
S-transferase alpha-4
(GSTA4)
Cytoplasm GSH-related
detoxification
betaine-
homocysteine
S-methyltransferase 1
(BHMT1)
Cytoplasm cysteine metabolism
and GSH synthesis
regulation
Bckdha protein Mitochondrion matrix Branched-chain amino
acids catabolism
Liver amelioration
dihydrofolate
reductase (DHFR)
Cytoplasm Synthesis of nucleic
acid precursors
quinoid
dihydropteridine
reductase (QDPR)
Cytoplasm.
Synaptosome
Tetrahydrobiopterin
recycle, amino acid
metabolism
glyceraldehyde-3-
phosphate
dehydrogenase
(GAPDH)
Cytoplasm. Nucleus. Glucose metabolism,
initiation of apoptosis
ribonuclease UK114 Mitochondrion.
Cytoplasm. Nucleus.
Peroxisome
Translational inhibition
galectin-5 Cytoplasm Cell surface
of rat reticulocytes and
erythrocytes
Erythrocyte
differentiation and
reticulocyte
maturation
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maturation, but its function in liver injury remains un-
clear [44,45]. The much higher expression of galectin-5
in the PLP group suggests that PLP may promote
erythropoiesis, inflammation regulation, and liver
regeneration.
Based on the proteomics data, we propose that the
antioxidant pathway, iron metabolism pathway, and
metabolic regulation of amino acids and nucleic acids
are a few key networks involved in the hepatoprotective
effect of PLP against TAA (Figure 6). Our western blot
analyses further indicated that the PLP-mediated protec-
tion against TAA-induced hepatic injury involves the
heat shock pathway. HSP70 has a crucial cytoprotective
function mediated by its function as a molecular
chaperone. A high level of HSP70 is a stress marker for
liver injury [46,47]. The aspect of whether the reduced
level of HSP70 represented a less inflammatory state of
the TAA-treated liver with PLP treatment awaits con-
firmation by functional proteomics analyses in future
studies.
Conclusion
The present study has demonstrated that PLP can pro-
tect rats against TAA-induced liver fibrosis in at least
two possible ways: 1) protection of the liver against oxi-
dative stress, especially by scavenging of iron-related free
radicals; and 2) regulation of the metabolism of amino
acids and nucleic acids for liver amelioration. Our find-
ings provide novel molecular mechanisms for the pro-
tective effects of P. linteus against liver fibrosis.
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